ACRV News
Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.
| Date | Type | Publisher | Headline | Summary |
|---|---|---|---|---|
| 2026-08-12 | Current report | SEC filing | Acrivon Therapeutics, Inc. filed Form 8-K | Acrivon Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2026-06-17 | Current report | SEC filing | Acrivon Therapeutics, Inc. filed Form 8-K | Acrivon Therapeutics, Inc. filed Form 8-K covering items 5.02,5.07,9.01. |
| 2026-05-13 | Current report | SEC filing | Acrivon Therapeutics, Inc. filed Form 8-K | Acrivon Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2026-03-19 | Current report | SEC filing | Acrivon Therapeutics, Inc. filed Form 8-K | Acrivon Therapeutics, Inc. filed Form 8-K covering items 2.02,7.01,9.01. |
| 2026-03-02 | Current report | SEC filing | Acrivon Therapeutics, Inc. filed Form 8-K | Acrivon Therapeutics, Inc. filed Form 8-K covering items 1.02. |
| 2026-02-27 | Current report | SEC filing | Acrivon Therapeutics, Inc. filed Form 8-K | Acrivon Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01. |
| 2026-01-08 | Current report | SEC filing | Acrivon Therapeutics, Inc. filed Form 8-K | Acrivon Therapeutics, Inc. filed Form 8-K covering items 2.02,7.01,8.01,9.01. |
| 2026-01-08 | Current report | SEC filing | Acrivon Therapeutics, Inc. filed Form 8-K | Acrivon Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01. |
| 2025-11-13 | Current report | SEC filing | Acrivon Therapeutics, Inc. filed Form 8-K | Acrivon Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2025-09-05 | Current report | SEC filing | Acrivon Therapeutics, Inc. filed Form 8-K | Acrivon Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01. |
| 2025-08-13 | Current report | SEC filing | Acrivon Therapeutics, Inc. filed Form 8-K | Acrivon Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2025-06-13 | Current report | SEC filing | Acrivon Therapeutics, Inc. filed Form 8-K | Acrivon Therapeutics, Inc. filed Form 8-K covering items 5.07. |
| 2025-05-14 | Current report | SEC filing | Acrivon Therapeutics, Inc. filed Form 8-K | Acrivon Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2025-04-07 | Current report | SEC filing | Acrivon Therapeutics, Inc. filed Form 8-K | Acrivon Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01. |
| 2025-03-27 | Current report | SEC filing | Acrivon Therapeutics, Inc. filed Form 8-K | Acrivon Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01. |
| 2025-03-25 | Current report | SEC filing | Acrivon Therapeutics, Inc. filed Form 8-K | Acrivon Therapeutics, Inc. filed Form 8-K covering items 2.02,7.01,8.01,9.01. |
| 2025-03-14 | Current report | SEC filing | Acrivon Therapeutics, Inc. filed Form 8-K | Acrivon Therapeutics, Inc. filed Form 8-K covering items 5.02,9.01. |
| 2024-11-13 | Current report | SEC filing | Acrivon Therapeutics, Inc. filed Form 8-K | Acrivon Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2024-10-11 | Current report | SEC filing | Acrivon Therapeutics, Inc. filed Form 8-K | Acrivon Therapeutics, Inc. filed Form 8-K covering items 7.01,8.01,9.01. |
| 2024-09-16 | Current report | SEC filing | Acrivon Therapeutics, Inc. filed Form 8-K | Acrivon Therapeutics, Inc. filed Form 8-K covering items 7.01,8.01,9.01. |
| 2024-08-13 | Current report | SEC filing | Acrivon Therapeutics, Inc. filed Form 8-K | Acrivon Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2024-06-21 | Current report | SEC filing | Acrivon Therapeutics, Inc. filed Form 8-K | Acrivon Therapeutics, Inc. filed Form 8-K covering items 5.07. |
| 2024-05-14 | Current report | SEC filing | Acrivon Therapeutics, Inc. filed Form 8-K | Acrivon Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2024-04-24 | Current report | SEC filing | Acrivon Therapeutics, Inc. filed Form 8-K | Acrivon Therapeutics, Inc. filed Form 8-K covering items 2.02,7.01,8.01,9.01. |
| 2024-04-09 | Current report | SEC filing | Acrivon Therapeutics, Inc. filed Form 8-K | Acrivon Therapeutics, Inc. filed Form 8-K covering items 1.01,3.02,7.01,9.01. |
| 2024-03-28 | Current report | SEC filing | Acrivon Therapeutics, Inc. filed Form 8-K | Acrivon Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2024-03-04 | Current report | SEC filing | Acrivon Therapeutics, Inc. filed Form 8-K | Acrivon Therapeutics, Inc. filed Form 8-K covering items 5.02,9.01. |
| 2024-02-08 | Current report | SEC filing | Acrivon Therapeutics, Inc. filed Form 8-K | Acrivon Therapeutics, Inc. filed Form 8-K covering items 5.02,9.01. |
| 2024-01-08 | Current report | SEC filing | Acrivon Therapeutics, Inc. filed Form 8-K | Acrivon Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01. |
| 2023-12-08 | Current report | SEC filing | Acrivon Therapeutics, Inc. filed Form 8-K | Acrivon Therapeutics, Inc. filed Form 8-K covering items 1.01. |
| 2023-11-09 | Current report | SEC filing | Acrivon Therapeutics, Inc. filed Form 8-K | Acrivon Therapeutics, Inc. filed Form 8-K covering items 2.02,7.01,9.01. |
| 2023-09-05 | Current report | SEC filing | Acrivon Therapeutics, Inc. filed Form 8-K | Acrivon Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01. |
| 2023-08-11 | Current report | SEC filing | Acrivon Therapeutics, Inc. filed Form 8-K | Acrivon Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2023-06-22 | Current report | SEC filing | Acrivon Therapeutics, Inc. filed Form 8-K | Acrivon Therapeutics, Inc. filed Form 8-K covering items 5.07. |
| 2023-06-05 | Current report | SEC filing | Acrivon Therapeutics, Inc. filed Form 8-K | Acrivon Therapeutics, Inc. filed Form 8-K covering items 1.01,9.01. |
| 2023-05-09 | Current report | SEC filing | Acrivon Therapeutics, Inc. filed Form 8-K | Acrivon Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2023-05-01 | Current report | SEC filing | Acrivon Therapeutics, Inc. filed Form 8-K | Acrivon Therapeutics, Inc. filed Form 8-K covering items 2.02. |
| 2023-05-01 | Current report | SEC filing | Acrivon Therapeutics, Inc. filed Form 8-K | Acrivon Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01. |
| 2023-04-25 | Current report | SEC filing | Acrivon Therapeutics, Inc. filed Form 8-K | Acrivon Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01. |
| 2023-03-28 | Current report | SEC filing | Acrivon Therapeutics, Inc. filed Form 8-K | Acrivon Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2023-03-13 | Current report | SEC filing | Acrivon Therapeutics, Inc. filed Form 8-K | Acrivon Therapeutics, Inc. filed Form 8-K covering items 2.02,7.01,9.01. |
| 2023-03-03 | Current report | SEC filing | Acrivon Therapeutics, Inc. filed Form 8-K | Acrivon Therapeutics, Inc. filed Form 8-K covering items 8.01. |
| 2022-11-17 | Current report | SEC filing | Acrivon Therapeutics, Inc. filed Form 8-K | Acrivon Therapeutics, Inc. filed Form 8-K covering items 3.02,5.03,8.01,9.01. |